The Agency for Healthcare Research and Quality has pledged $5.8 million in new funds to states participating in an initiative to curb rates of central line-associated bloodstream infections. The increased funding comes less than a year after AHRQ announced it would expand the program—known as On the CUSP: STOP BSI—to all 50 states.
$5.8 million marked for anti-infection efforts
The Chicago-based Health Research and Educational Trust is charged with dispersing funds for the program, according to a news release.
On the CUSP: STOP BSI was developed by Johns Hopkins University's Quality & Safety Research Group in Baltimore, and it received widespread attention after more than 100 Michigan intensive-care units implemented the protocols and dramatically lowered their rates of central line infections. The project has expanded rapidly and now includes 900 hospitals in 30 states, HRET said in the release.
States can apply for up to $70,000 to cover staffing costs associated with the program, and funding opportunities will extend to both current and future participants.
“The On the CUSP: STOP BSI team is delighted that state funding has been approved,” John Combes, senior vice president of the American Hospital Association, said in the release. Combes leads the program alongside Peter Pronovost, director of the Quality & Safety Research Group.
“This support will go a long way to ensuring the sustainability of state efforts over time,” Combes said.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.